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Myocarditis   
Plan of the Lecture   
• Definition 
• Epidemiology 
• Risk factors 
• Etiology 
• Mechanisms  
• Classification 
• Clinical investigation 
• Diagnosis 
• Treatment   
• Prognosis 
• Prophylaxis 
• Abbreviations  
• Diagnostic and treatment guidelines 
http://circ.ahajournals.org/content/circulationaha/113/6/876/F1.large.jpg 
Definition  
Myocarditis is an inflammatory disease of the myocardium 
with a wide range of clinical presentations, from subtle to 
devastating, diagnosed by established histological, 
immunological and immunohistochemical criteria. 
http://eurheartj.oxfordjournals.org/content/34/33/2636 http://emedicine.medscape.com/article/156330-overview 
 US MLE TEST 
A 10-year-old male presents with multiple complaints. A few weeks ago, 
he had a sore throat that improved without specific therapy. Over the 
past several days he has experienced pain in his ankles and wrists and, 
more recently, his left knee. His mother noted several bumps on both of 
his elbows. He thinks the pain is better when he leans forward. On 
physical examination, he is noted to be mildly febrile, and a pericardial 
friction rub is auscultated. Which of the histopathologic findings is most 
likely associated with this patient's condition?  
1.Atypical lymphocytes noted on peripheral blood smear, 2.Plasmodium 
falciparum ring forms in red blood cells on peripheral blood smear, 
3.Needle-shaped, negatively birefringent crystal deposits surrounded by 
palisading histiocytes in the synovial fluid of an affected joint, 4. 
Interstitial myocardial granulomas containing plump macrophages with 
nuclei incorporating central wavy ribbons of chromatin, 5.  Sterile 
vegetations on both the ventricular and atrial aspects of the mitral 
valve.  https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient's presentation is consistent with a 
diagnosis of acute rheumatic fever and associated carditis. Histologic 
findings associated with this condition include Aschoff bodies, 
interstitial myocardial granulomas composed of surrounding Anitschkow 
or caterpillar cells, which are plump macrophages with abundant 
cytoplasm and central, ovoid nuclei with slender ribbons of chromatin. 
Incorrect Answers: 1.Atypical lymphocytosis is consistent with a 
diagnosis of infectious mononucleosis caused by EBV. 2.This finding is 
consistent with a diagnosis of malaria. 3.The deposition of monosodium 
urate crystals in synovial fluid describes the histological findings 
associated with gout. 5. These findings are consistent with a diagnosis of 
systemic lupus erythematous (SLE). 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Epidemiology   
  
http://emedicine.medscape.com/article/156330-overview#a6 
• Incidence is estimated at 1-10 cases per 100,000 persons.  
• Incidence of positive right ventricular biopsy findings in 
patients with suspected myocarditis is highly variable 
(ranging from 0-80%).  
• As many as 1-5% of patients with acute viral infections may 
have involvement of the myocardium. 
• No particular race predilection is noted for myocarditis 
except for peripartum cardiomyopathy that appears to 
have a higher incidence in patients of African descent. 
• The incidence of myocarditis is similar between males and 
females. 
• Patients are usually fairly young.   
Risk Factors and Etiology: 1   
  Infections 
• Viral (adenovirus, parvovirus B19, coxsackie virus, human 
immunodeficiency virus (HIV), enterovirus, rubella 
virus, poliovirus, cytomegalovirus, human herpesvirus, and 
possibly hepatitis C). 
• Protozoan (Trypanosoma cruzi causing Chagas disease and 
Toxoplasma gondii). 
• Bacterial (Brucella, Corynebacterium diphtheriae, 
gonococcus, Haemophilus influenzae, Actinomyces, 
Tropheryma whipplei, Vibrio cholerae, Borrelia 
burgdorferi, leptospirosis, and Rickettsia, Mycoplasma 
pneumoniae). 
https://en.wikipedia.org/wiki/Myocarditis#Causes 
Risk Factors and Etiology: 2   
  • Fungal (Aspergillus). 
• Parasitic (Ascaris, Echinococcus granulosus, Paragonimus 
westermani, schistosoma, Taenia solium,Trichinella spiralis, 
visceral larva migrans, and Wuchereria bancrofti).  
• Toxins (arsenic, toxic shock syndrome toxin, carbon 
monoxide, heavy metals (copper, iron),  drugs (alcohol, 
anthracyclines, chemotherapy, antipsychotics, etc.). 
• Immunologic (allergic (acetazolamide, amitriptyline), 
rejection after a heart transplant, autoantigens 
(scleroderma, systemic lupus erythematosus, 
sarcoidosis, Kawasaki disease, etc.).   
• Physical agents (electric shock, hyperpyrexia, radiation). 
https://en.wikipedia.org/wiki/Myocarditis#Causes 
Mechanisms 1    
(Viral and Autoimmune) 
http://eurheartj.oxfordjournals.org/content/34/33/2636 
• There is evidence for viral and autoimmune mechanisms in 
individuals with or without a genetic predisposition. 
• Enteroviruses that preferentially enter cardiomyocytes 
cause severe cytopathic effects due to virus replication in 
the first 2 weeks post-infection.  
• The ongoing infection and inflammation trigger 
autoimmune reactions in the heart, most likely as a result 
of myocyte necrosis and subsequent release of self-
antigens previously hidden to the immune system.  
Mechanisms     
(From Myocarditis to Dilated Cardiomyopathy) 
http://eurheartj.oxfordjournals.org/content/34/33/2636 
Mechanisms 
(Histopathology and Immunopathology) 
  
http://eurheartj.oxfordjournals.org/content/34/33/2636 
Acute lymphocytic myocarditis 
(first row), chronic lymphocytic 
myocarditis (second row), 
sarcoidosis (third row), and giant 
cell myocarditis (fourth row). 
Left column = haematoxylin-
eosin; middle column = staining 
with anti-CD3 antibody (pan T 
lymphocyte marker); right 
column = staining with anti-
CD68 antibody (macrophage 
marker).  
Mechanisms 
(Histopathology and Immunopathology) 
  
http://eurheartj.oxfordjournals.org/content/34/33/2636 
Short-axis (upper line) and long-axis (lower line) images of a 
patient with acute myocarditis. The presence of patchy focal 
edema in the subepicardium of the inferolateral wall (red 
arrows). Presence of subepicardially distributed LGE (red 
arrows) which is typical for acute myocarditis. 
Classification 
(International Classification of Diseases (ICD) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
 
I01.2 Acute rheumatic myocarditis. 
I40.0 Infective myocarditis. 
I40. 1 Isolated myocarditis. 
I40.8 Other acute myocarditis. 
I40.9 Acute myocarditis, unspecified. 
I41 Myocarditis in diseases classified elsewhere (diphtheritic,  
gonococcal, meningococcal, syphilitic, tuberculous, influenzal, 
parasitic, rheumatoid, sarcoid, myocardial fibrosis). 
Classification 
(Etiology, Cell Type, Clinical Type) 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Classification 
(Lieberman’ Classification) 
http://emedicine.medscape.com/article/156330-overview#a4 
• Fulminant myocarditis: follows a viral prodrome; distinct 
onset of illness consisting of severe cardiovascular 
compromise with ventricular dysfunction and multiple foci 
of active myocarditis. 
• Acute myocarditis: less distinct onset of illness, with 
ventricular dysfunction. 
• Chronic active myocarditis : less distinct onset of illness, 
with clinical and histologic relapses, with ventricular 
dysfunction. 
• Chronic persistent myocarditis: less distinct onset of illness; 
persistent histologic infiltrate with foci of myocyte necrosis 
without ventricular dysfunction. 
Classification 
(The Dallas Classification (1987)) 
http://emedicine.medscape.com/article/156330-workup#c12 
Initial biopsy: 
• Myocarditis: necrosis, degeneration, or both, in the 
absence of significant coronary artery disease with adjacent 
inflammatory infiltrate with or without fibrosis. 
• Borderline myocarditis: inflammatory infiltrate too sparse 
or myocyte damage not apparent/ 
• No myocarditis. 
Subsequent biopsy: 
• Ongoing (persistent) myocarditis with or without fibrosis. 
• Resolving (healing) myocarditis with or without fibrosis. 
• Resolved (healed) myocarditis with or without fibrosis. 
Classification 
(WHO Marburg Сriteria (1996)) 
http://carditis.net/whfmyoca.htm 
First biopsy: 
1. Acute myocarditis: a clear-cut infiltrate of >14 
leukocytes/mm² (preferably activated T-cells).   
2. Chronic myocarditis : an infiltrate of >14 leukocytes/mm² 
(preferably activated T-cells).   
3. No myocarditis: No infiltrating cells, <14 leukocytes/mm². 
Subsequent biopsies: 
1. Ongoing (persistent) myocarditis. Criteria as in 1 or 2. 
2. Resolving (healing) myocarditis. Criteria as in 1 or 2 but the 
immunological process is sparser than in the first biopsy. 
3. Resolved (healed) myocarditis (the Dallas classification). 
Clinical Investigation  
(Signs and Symptoms) 
• Fever, cardiac rhythm disturbance, hypotension, gallop 
rhythm, rales, jugular venous dilatation, and cardiac 
tamponade. 
• Flu-like symptoms (chills, fever, headache, muscle aches, 
general malaise). 
• Cardiac symptoms (a few hours to a few days after the 
initial signs and symptoms): heart failure, chest pain due to 
pericardial irritation, heart block and arrhythmia.  
• Gastrointestinal symptoms: decreased appetite, nausea, 
vomiting, and diarrhea. 
 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Clinical Investigation  
(Course of the Disease) 
• The primary signs and symptoms and disease progression 
of myocarditis are relatively easy to grasp.  
• The inflammatory phase lasts one to two weeks, and is 
followed by a recovery phase.  
• Myocarditis causes myocardial necrosis and inflammation, 
which result in cardiac dysfunction and failure.  
• Myocarditis usually manifests in an otherwise healthy 
person and can result in rapidly progressive (and often 
fatal) heart failure and arrhythmia.  
http://emedicine.medscape.com/article/156330-overview  https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Clinical Investigation  
(Specific Findings in Special Cases) 
• Sarcoid myocarditis: lymphadenopathy, sarcoid 
involvement in other organs (up to 70%). 
• Acute rheumatic fever (affects heart in 50-90%; associated 
signs: erythema marginatum, polyarthralgia, chorea, 
subcutaneous nodules (Jones criteria). 
• Hypersensitive/eosinophilic myocarditis (pruritic 
maculopapular rash and history of using offending drug). 
• Giant cell myocarditis (ventricular tachycardia in rapidly 
progressive heart failure). 
• Peripartum cardiomyopathy (heart failure in the last month 
of pregnancy or within 5 months following delivery). 
http://emedicine.medscape.com/article/156330-overview 
 US MLE TEST 
A 45-year-old African American woman presents to her family 
physician for a routine examination. Past medical history is 
positive for amyloidosis and non-rhythm-based cardiac 
abnormalities secondary to the amyloidosis. Which of the 
following cardiac parameters would be expected in this 
patient?  
1.  Preserved ejection fraction and increased compliance.  
2.  Preserved ejection fraction and decreased compliance.  
3.  Decreased ejection fraction and increased compliance.  
4.  Decreased ejection fraction and decreased compliance.  
5.  Increased ejection fraction and decreased compliance. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient has diastolic heart failure 
secondary to amyloidosis. Diastolic heart failure is 
characterized by a decrease in ventricular compliance with 
normal contractility (preserved ejection fraction).  
Incorrect Answers: 1,3-5: These cardiac parameters are not 
generally seen in a patient with diastolic heart failure. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Diagnosis 
(Instrumental)  
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
• Chest X-Ray: hear enlargement and pulmonary congestion.  
• Electrocardiography (ECG):  abnormal ST-T waves, 
conduction block, increase in the width of the QRS 
complex, potentially fatal arrhythmias.  
• Echocardiography: transient wall thickening, reduced wall 
motion, reduced cardiac chamber size, pericardial effusion. 
• Cardiac magnetic (CMR) and magnetic resonance imaging 
(MRI): the regions of the heart affected by inflammation.  
• Cardiac catheterization including endomyocardial biopsy: 
myocardial degeneration, myocyte necrosis, inflammatory 
infiltrates, and/or interstitial edema of the myocardium.   
Diagnosis 
(ECG)  
http://www.isarherzzentrum.de/en/myocarditis 
Ventricular tachycardia (rapid ventricular rhythm disorder)     
in myocarditis. 
Diagnosis 
(Echocardiography)  
http://www.isarherzzentrum.de/en/myocarditis 
Circulatory disorder (red) in an acute myocarditis. 
Diagnosis 
(Magnetic Resonance Imaging)  
http://www.isarherzzentrum.de/en/myocarditis 
Representation of edema in acute myocarditis (arrow indicators). 
A pericardial effusion, aka fluid around the heart (star). 
Diagnosis 
(Endomyocardial Biopsy)  
http://www.isarherzzentrum.de/en/myocarditis 
Hematoxylin and eosin staining of the biopsy sample reveals 
extensive myocyte necrosis, cellular inflammation and the 
formation of multinucleated giant cells (arrows). 
Diagnosis 
(Diagnostic Criteria for Acute Myocarditis in 
Endomyocardial Biopsy) 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
• Infiltration of many large or small mononuclear cells* 
(occasionally, a few polymorphonuclear leukocytes and 
multinucleated giant cells appear). 
• Rupture, fusion and disappearance of cardiomyocytes. 
• Interstitial edema (occasionally with fibril formation). 
 
*Cell infiltrates are often observed adjacent to 
cardiomyocytes. 
Diagnosis 
(Laboratory Studies)  
http://emedicine.medscape.com/article/156330-overview 
• Complete blood count (CBC): leukocytosis (may 
demonstrate eosinophilia). 
• Elevated erythrocyte sedimentation rate (other acute phase 
reactants, such as C-reactive protein). 
• Rheumatologic screening : to rule out systemic 
inflammatory diseases, 
• Elevated cardiac enzymes: transient elevation of C-reactive 
protein (CRP), aspartate aminotransferase (AST), lactate 
dehydrogenase (LDH), the MB form creatine kinase (CK-
MB), and cardiac troponin T in blood. 
• Serum viral antibody titers: for viral myocarditis. 
Diagnosis 
(Viral Infection) 
  
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
• Viral infection is confirmed if the viral antibody titer is at 
least four times higher in an acute phase serum sample 
than in a sample obtained in remission phase collected at 
least two weeks apart.  
• Only approximately 10% of patients with viral infection 
exhibit a positive antibody titer.  
• Polymerase chain reaction (PCR) is more useful for 
identifying the genomes of viruses causing myocarditis, but 
is not commonly performed. 
Diagnosis 
(Differential Diagnoses) 
  
http://emedicine.medscape.com/article/156330-differential 
• Alcoholic Cardiomyopathy. 
• Cardiac Tamponade. 
• Cardiogenic Shock. 
• Chagas Disease (American Trypanosomiasis). 
• Cocaine-Related Cardiomyopathy. 
• Coronary Artery Atherosclerosis. 
• Dilated Cardiomyopathy. 
• Hypertrophic Cardiomyopathy. 
• Peripartum Cardiomyopathy. 
• Restrictive Cardiomyopathy. 
Treatment 
(Diet and Physical Activity) 
• Patients should consume a low-sodium diet similar to that 
for heart failure management.   
• Physical activity should be restricted to reduce the work of 
the heart during the acute phase of myocarditis. 
• Terms of physical activity limitation: 
• 10 – 14 days – mild myocarditis (up to ECG 
normalization), 
•   4 – 6 weeks – moderate myocarditis (up to 
normalization of heart size), 
• individually – severe myocarditis (up to decreasing of HF 
severity and disappearance of rhythm disorders).  
http://emedicine.medscape.com/article/156330-treatment  https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Treatment 
(Tasks) 
Myocarditis is  treated in three ways: (1) intervention to 
eliminate the cause, (2) intervention to improve hemodynamic 
compromise, and (3) intervention in cardiac dysfunction. 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Treatment 
(Etiotropic) 
• Antibiotic therapy only after the confirmation of the 
etiological factor (diphtheria). 
• Antiviral drugs only for proven viral myocarditis (etiologic 
agent is known AND sensitive to antiviral drug), however, 
beneficial effects are seen only if therapy is started prior to 
inoculation or soon thereafter.  
• Nevertheless, antiviral therapy may be considered in acute, 
fulminant myocarditis, in institutional outbreaks and in 
laboratory-acquired cases. 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Treatment 
(Intensive Immunosuppressive Therapy) 
• Intensive immunosuppressive therapy (e.g., corticosteroids, 
azathioprine, cyclosporine, muromonab-CD3/OKT3) has 
been shown to have some benefit only in small-scale 
clinical studies in the treatment of giant cell myocarditis 
and has not been validated in large clinical trials.  
• At this time, immunosuppressive therapy is not 
recommended for myocarditis until clear evidence is 
available from the results of multicenter trials. 
http://emedicine.medscape.com/article/156330-overview 
Treatment 
(Pathogenetic Pharmacotherapy) 
• Vasodilators (e.g., nitroglycerin, sodium nitroprusside). 
• Angiotensin-converting enzyme inhibitors. 
• Diuretics (e.g., furosemide). 
• Anticoagulation may be advisable as a preventive measure. 
• Antiarrhythmics can be used cautiously, although most 
antiarrhythmic drugs have negative inotropic effects that 
may aggravate heart failure; supraventricular arrhythmias 
should be converted electrically. 
• Inotropic drugs (e.g., dobutamine, milrinone) may be 
necessary for severe decompensation, although they are 
highly arrhythmogenic. 
http://emedicine.medscape.com/article/156330-overview 
Treatment 
(Supportive Care and Surgical Intervention) 
• Hemodynamic and cardiac monitoring, 
• Administration of supplemental oxygen, 
• Fluid management, 
• Temporary transvenous pacing for complete heart block, 
• Cardiac transplantation, 
• Extreme cases: ventricular assist device or percutaneous 
circulatory support; left ventricular assistive devices 
(LVADs) and extracorporeal membrane oxygenation. 
http://emedicine.medscape.com/article/156330-overview 
Consultations 
• Cardiothoracic surgery. 
• Infectious disease and/or 
rheumatology 
consultations. 
http://emedicine.medscape.com/article/156330-treatment 
Rheumatic heart disease 
Prognosis  
• In the acute phase, myocarditis management of cardiac 
pump failure and potentially fatal arrhythmias is the main 
clinical challenge.  
• The prognosis of myocarditis varies depending on the 
pathogenesis and type of disease. 
• Patients who survive fulminant myocarditis have a good 
prognosis.  
• Predictors of death or need for heart transplantation 
include syncope, low ejection fraction, and left bundle-
branch block, all indicators of advanced cardiomyopathy. 
https://www.jstage.jst.go.jp/article/circj/75/3/75_CJ-88-0008/_pdf 
Prophylaxis 
• Vaccination should reduce the incidence of myocarditis 
caused by measles, rubella, mumps, poliomyelitis, and 
influenza.  
• The development of vaccines for other cardiotropic viruses 
may prevent viral myocarditis in the future. 
http://emedicine.medscape.com/article/156330-treatment 
Abbreviations  
 ACE - angiotensin converting enzyme 
CMR - cardiac magnetic resonance 
ECG - electrocardiogram  
MRI - magnetic resonance imaging 
HIV - human immunodeficiency virus 
LVADs - left ventricular assistive devices   
  
Diagnostic and treatment guidelines 
Current state of knowledge on etiology, diagnosis, management, and 
therapy of myocarditis: a position statement of the European Society of 
Cardiology Working Group on Myocardial and Pericardial Diseases 
Guidelines for Diagnosis and Treatment of Myocarditis    
 2015 ESC Guidelines for the management of infective endocarditis 
2015 ESC Guidelines for the diagnosis and management of pericardial 
diseases 
Update on Myocarditis 
 
 
 Cardiomyopathies  
Plan of the Lecture   
• Definition 
• Epidemiology 
• Risk factors 
• Etiology 
• Mechanisms  
• Classification 
• Clinical investigation 
• Diagnosis 
• Treatment   
• Prognosis 
• Prophylaxis 
• Abbreviations  
• Diagnostic and treatment guidelines 
http://library.med.utah.edu/WebPath/CVHTML/CV093.html 
A large, dilated left ventricle typical of a 
dilated, or congestive, cardiomyopathy   
Definition  
Cardiomyopathies (CM) are defined by structural and 
functional abnormalities of the ventricular myocardium that 
are unexplained by flow-limiting coronary artery disease or 
abnormal loading conditions and historically have been 
subdivided into primary disease, in which the heart is the only 
involved organ, and secondary forms where the 
cardiomyopathy is a manifestation of a systemic disorder.   
http://eurheartj.oxfordjournals.org/content/early/2014/08/28/eurheartj.ehu284  
 US MLE TEST 
A 20-year-old male presents to his primary care physician for 
a sports physical. If the physician is worried about 
hypertrophic cardiomyopathy in this patient, what physical 
examination finding and hereditary pattern would be 
expected for this disease process? 
1.  No change in murmur intensity with valsalva; X-linked 
recessive, 2.  Decreased murmur intensity with valsalva; X-
linked recessive, 3.  Decreased murmur intensity with 
valsalva; autosomal dominant, 4.  Increased murmur intensity 
with valsalva; autosomal dominant, 5.  Increased murmur 
intensity with valsalva; X-linked recessive.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 4:    Hypertrophic cardiomyopathy (HCM) will 
present with a systolic murmur that increases in intensity with 
the valsalva maneuver. HCM is inherited in an autosomal 
dominant fashion.  
 Incorrect Answers: 1-3 & 5: None of these combinations of 
murmur alterations and inheritance patterns are correct for 
the specific pathology of hypertrophic cardiomyopathy.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Epidemiology  
(Dilated Cardiomyopathy) 
 emedicine.medscape.com/article/2017823-overview#a3 heart.org/HEARTORG/Conditions/More/Cardiomyopathy/Dilated-Cardiomyopathy_UCM_444187_Article.jsp#.V34FCLiLQhc 
• The estimated prevalence of dilated cardiomyopathy (DCM) 
is 1:2500. 
• The incidence of DCM discovered at autopsy is estimated to 
be 4.5 cases per 100,000 population per year, whereas the 
clinical incidence is 2.45 cases per 100,000 population per 
year. 
• DCM is the most common type, occurring mostly in 
adults 20 to 60.  
• Men are more likely in men than in women. 
Epidemiology  
(Hypertrophic Cardiomyopathy) 
http://bestpractice.bmj.com/best-practice/monograph/409/basics/epidemiology.html 
• Hypertrophic cardiomyopathy (HCM) occurs with an 
incidence of 1 in 500 people in the general population and 
is the most common cause of sudden death in children and 
adults under 35 years. 
• The mean age is 57 (16 to 87) years.  
• HCM is autosomal dominant with no known sex 
predilection. 
• Sudden death is most common in young patients, and 
death from heart failure or stroke occurs more frequently 
in middle age and beyond. 
• Apical HCM is seen much more commonly in Asian people.   
Epidemiology 
(Distribution of Myocardial Diseases According to the 
Manner of Death)   
http://www.revespcardiol.org/en/myocardial-disease-mortality-in-children/articulo/13086406/ 
Risk Factors and Etiology 
(Dilated Cardiomyopathy)   
• DCM can be familial, primary without family history, or 
secondary (associated with or caused by other conditions).  
• Familial DCM (>25% of cases of DCM), is usually autosomal 
dominant. 
• 2 of 3 patients have sporadic DCM and about 15% of them 
arise from chronic myocarditis.   
• Noninflammatory etiologies and associations include 
alcoholism; anthracycline drugs; ingestion of metals; 
autoimmune, systemic and mitochondrial disorders. 
• The distinction between the cause and risk factor(s) DCM is 
sometimes blurred. 
http://emedicine.medscape.com/article/2017823-overview#a2 
Risk Factors and Etiology 
(Hypertrophic Cardiomyopathy)   
• Abnormal calcium kinetics leads to the inappropriate 
myocardial hypertrophy and specific features of HCM, 
particularly in patients with diastolic functional 
abnormalities. 
• Genetic causes (an autosomal dominant Mendelian-
inherited disease in approximately 50% of cases (at least 6 
different genes on at least 4 chromosomes are associated 
with HCM, with more than 50 different mutations 
discovered thus far)). 
• Other causes: abnormal sympathetic stimulation; 
abnormally thickened intramural coronary arteries; 
subendocardial ischemia; cardiac structural abnormalities.   
http://emedicine.medscape.com/article/152913-overview 
Risk Factors and Etiology 
(Diverse Etiology of Hypertrophic Cardiomyopathy)   
  
http://eurheartj.oxfordjournals.org/content/early/2014/08/28/eurheartj.ehu284 
 US MLE TEST 
A 17-year-old previously healthy, athletic male suddenly falls 
unconscious while playing soccer. His athletic trainer comes to 
his aid and notes that he is pulseless. He begins performing 
CPR on the patient until the ambulance arrives and 
pronounces the teenager dead. What is the mechanism 
behind the most likely cause of death?    
1.  Myocardial infarction.  
2.  Heart failure due to diastolic dysfunction.  
3.  Arrhythmia.  
4.  Outflow obstruction.  
5.  Rapid volume loss.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 3:  This case of sudden death is most likely 
caused by a ventricular arrhythmia that arises from 
hypertrophic cardiomyopathy.  
Incorrect Answers: 1: It is unlikely that an athletic 17-year-old 
with no past medical history would have a myocardial 
infarction, 2: Diastolic dysfunction occurs when there is not 
enough filling space in the heart resulting in a low stroke 
volume; although this can be seen in hypertrophic 
cardiomyopathy, it is not the primary cause of death, 4: 
Outflow obstruction occurs in hypertrophic cardiomyopathy 
but it is not the main cause of death, 5: Rapid volume loss, 
such as in bleeding, is unlikely in the patient scenario. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Mechanisms 
(Dilated Cardiomyopathy: Gross Findings)    
  
http://emedicine.medscape.com/article/2017823-overview#a9 
• Cardiomegaly is a requisite for the diagnosis of DCM (the 
mean heart weight is about 600 g). 
• Typically, 4-chamber dilatation that is greater in the 
ventricles than the atria is found.   
• LV wall thickness is often normal, in contrast to 
hypertensive cardiomyopathy with failure.  
• Mitral insufficiency may result from papillary muscle 
dysfunction secondary to LV and changes in LV wall shape, 
and tricuspid regurgitation results from annular dilatation. 
• Mural thrombi are common in patients who do not receive 
anticoagulation.  
• Diffuse or patchy endocardial fibrosis is frequent. 
Mechanisms 
(Dilated Cardiomyopathy: Gross Findings)    
  
http://emedicine.medscape.com/article/2017823-overview#a9 
Gross heart specimen from a patient with DCM who died in 
end-stage heart failure. Defibrillator leads are in the right 
heart. The ventricles are dilated more than the atria. 
Mechanisms 
(Dilated Cardiomyopathy: Microscopic Findings)    
  
http://emedicine.medscape.com/article/2017823-overview#a9 
• The histologic features of DCM are nonspecific.  
• In biopsies, the findings range from minimal variation in 
myocyte size to typical features of myofiber loss, interstitial 
fibrosis, and marked variation in myofiber size.  
• Transmural scars may also occur in dilated cardiomyopathy.  
• Quantitation of collagen has shown up to 4 times the 
normal collagen concentration, with a decrease in mature 
cross-linked collagen, correlating with an increase in 
neutrophil-type collagenase activity. 
• The volume density of myofibrils is reduced, and 
mitochondrial density is normal, but the mitochondria are 
more numerous and small.  
 
Mechanisms 
(Dilated Cardiomyopathy: Microscopic Findings)    
  
http://emedicine.medscape.com/article/2017823-overview#a9 
Heart section from a cardiac explant in a patient with end-
stage DCM. There is focal interstitial fibrosis. The change is 
nonspecific and can be seen in heart failure from any cause. 
Mechanisms 
(Dilated Cardiomyopathy: Immunohistochemistry)    
  
http://emedicine.medscape.com/article/2017823-overview#a9 
• Immunolocalization of sarcomeric and cytoskeletal proteins 
have demonstrated abnormal distribution in explanted 
hearts from patients with DCM.  
• Tubulin and desmin are increased in amount and irregularly 
distributed. 
• Titin, a member of the sarcomeric skeleton family, is 
reduced, in areas where contractile material is lacking. 
• Connexin-43 is also decreased. 
• Increased myocyte cell death and apoptosis is found. 
• In cases of dystrophin-related dilated cardiomyopathy, 
immunohistochemical and molecular studies are essential 
to identify protein and gene defects. 
Mechanisms 
(Dilated Cardiomyopathy: Immunohistochemistry)    
  
http://emedicine.medscape.com/article/2017949-overview 
Arrhythmogenic right ventricular cardiomyopathy (ARVC).  
Mechanisms 
(Hypertrophic Cardiomyopathy (HCM): Gross Findings)  
http://pathologyoutlines.com/topic/hearthypertrophic.html 
• About 1/4 individuals demonstrate an obstruction to the 
outflow of blood from the LV during rest and in 70% of 
patients, obstruction can be provoked under certain 
conditions (dynamic outflow obstruction). 
• Myocardial hypertrophy and extracellular fibrosis 
predispose to increased LV stiffness which in concert with 
compromised cellular energetics and abnormal calcium 
handling lead to diastolic dysfunction. 
• The altered structure of the coronary vessels and increased 
diastolic pressure, with the hypertrophy and outflow tract 
obstruction, may cause myocardial ischemia, and may 
trigger ventricular arrhythmias. 
Mechanisms 
(Hypertrophic Cardiomyopathy: Gross Findings) 
http://www.pathguy.com/sol/07811.jpg 
Mechanisms 
(Hypertrophic Cardiomyopathy: Microscopic Findings)  
http://pathologyoutlines.com/topic/hearthypertrophic.html 
• The earliest histological changes are myocyte disorganization 
which is widespread throughout the ventricles. 
• The interventricular septum demonstrates myocyte disarray, 
the hallmark of HCM. 
• The abnormal arrangement of large hypertrophied muscle 
bundles crossing each other. 
• The most sensitive and specific change is circular arrays of 
myocytes around central foci of connective tissue . 
• Cross sections of the sarcomere show a highly organized 
orthohexagonal array. 
•  The abnormal myosin interferes with the normal spatial 
arrangement of the myofibril.  
 
Mechanisms 
(Hypertrophic Cardiomyopathy: Microscopic Findings) 
http://www.wikidoc.org/index.php/File:3480.jpg 
Interstitial fibrosis with many fibroblastic cells. 
Mechanisms 
(Hypertrophic Cardiomyopathy: Pathophysiology)  
http:// http://emedicine.medscape.com/article/152913-overview#a3 
• The greatest factor is the dynamic pressure gradient across 
the LV outflow tract.   
• The explanations for the systolic anterior motion of the 
mitral valve (MV): (1) the MV is pulled against the septum 
by contraction of the papillary muscles; (2) the MV is 
pushed against the septum; (3) the MV is drawn toward the 
septum (Venturi effect). 
• Most patients have abnormal diastolic function, which 
impairs ventricular filling and increases filling pressure, 
despite a normal or small ventricular cavity.   
Mechanisms 
(Hypertrophic Cardiomyopathy: Pathophysiology) 
http://thoracickey.com/hypertrophic-cardiomyopathy-2/ 
Changes in left ventricular outflow tract obstruction. Ao, 
ascending aorta; LA, left atrium; LV, left ventricle. 
 US MLE TEST 
A 28-year-old female presents to her primary care physician 
complaining of a one-week history of fatigue, progressively 
worsening shortness of breath, and swelling of her feet and ankles. 
Her past medical history is unremarkable. Her temperature is 37 C 
(98.6 F), blood pressure is 120/70 mmHg, pulse is 84/min, and 
respiratory rate is 20/min. Her physical exam is also notable for 
bibasilar crackles, jugular venous distension, an S3 gallop, and 2+ 
pitting edema up to the ankles bilaterally. Her electrolytes and 
complete blood count are within normal limits. Transthoracic 
echocardiogram of her heart will likely show which of the 
following? 
1.  Mitral stenosis, 2.  Aortic valve vegetations, 3.  Idiopathic 
pulmonary arterial hypertension, 4.  Dilated ventricles with diffuse 
hypokinesia, 5.  Eccentric cardiac hypertrophy.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 4:  This patient has acute onset of congestive heart 
failure (CHF) following a recent upper respiratory tract infection, 
suggesting dilated cardiomyopathy secondary to acute viral 
myocarditis. Echocardiography would reveal dilated ventricles with 
diffuse hypokinesia. 
Incorrect Answers: 1: Mitral stenosis is characterized by a mid-
diastolic murmur and opening snap, with EKG evidence of left 
atrial hypertrophy, 2: Aortic valve vegetations would result from 
infective endocarditis, resulting in fevers, chills, and aortic 
regurgitation, 3: Idiopathic pulmonary arterial hypertension would 
typically present with dyspnea on exertion and isolated right-sided 
heart failure in more advanced cases. 5: Eccentric hypertrophy is 
seen in chronic volume overload and would not be present in 
acute CHF. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Classification 
(International Classification of Diseases (ICD): 1) 
apps.who.int/classifications/icd10/browse/2016/en#/I46 
142 Cardiomyopathy 
I42.0 Dilated (congestive) CM 
I42.1 Obstructive hypertrophic CM  
= hypertrophic subaortic stenosis 
I42.2 Other (nonobstructive) 
hypertrophic CM 
I42.3 Endomyocardial (eosinophilic) 
disease  
I42.4 Endocardial fibroelastosis 
(congenital CM) 
I42.5 Other restrictive 
cardiomyopathy  
I42.6 Alcoholic CM  
  
 I42.7 CM due to drugs and other 
external agents  
I42.8 Other CM  
I42.9 CM , unspecified  
I43* CM in diseases classified 
elsewhere 
I43.0* CM in infectious and 
parasitic diseases classified 
elsewhere 
CM in metabolic diseases  
CM in nutritional diseases  
CM in other diseases classified 
elsewhere  
Classification 
(Primary and Secondary) 
https://en.wikipedia.org/wiki/Cardiomyopathy 
• Primary/intrinsic cardiomyopathies: 
• Genetic (HCM, arrhythmogenic right ventricular 
CM (ARVC), left ventricle (LV) non-compaction, Ion 
Channelopathies, DCM, restrictive CM (RCM). 
• Acquired (stress CM, myocarditis, ischemic CM). 
• Secondary/extrinsic CM: metabolic/storage (Fabry’s 
disease, hemochromatosis), endomyocardial 
(endomyocardial fibrosis, hypereosinophilic syndrome), 
endocrine (diabetes mellitus, hyperthyroidism, 
acromegaly), cardiofacial (noonan syndrome), 
neuromuscular (muscular dystrophy, Friedreich’s ataxia), 
other (obesity-associated cardiomyopathy). 
Classification 
(World Health Organization Classification) 
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/dilated-restrictive-cardiomyopathy/ 
Type   Features Causative Factors 
Dilated Dilated left or both 
ventricle(s), with impaired 
contraction 
Ischemic, idiopathic, familial-genetic, 
immune, alcoholic, toxic, valvular 
Hypertrophic Left or right ventricular 
hypertrophy, or both 
Familial, with autosomal dominant 
inheritance 
Restrictive Restrictive filling and 
reduced diastolic filling of 
one or both ventricles  
Idiopathic, amyloidosis, 
endomyocardial fibrosis 
Arrhythmoge- 
nic right 
ventricular 
Fibrofatty replacement of 
right ventricular 
myocardium, Uhl's 
anomaly (parchment 
heart) 
Unknown; familial, with incomplete 
penetrance; possible autosomal 
recessive inheritance; rare forms (eg, 
Naxos disease) 
Unclassified Not typical for previous 
four groups 
Fibroelastosis, noncompacted 
myocardium, systolic dysfunction with 
minimal dilation, mitochondrial disease 
 
 
Clinical Investigation  
(Signs and Symptoms) 
Dilated Cardiomyopathy 
• Some patients remain 
asymptomatic throughout 
life. 
• Some patients have 
severe symptoms of heart 
failure; arrhythmias; 
systemic embolism; 
angina, but only in the 
presence of ischemic 
heart disease.   
 
Hypertrophic Cardiomyopathy 
• Some patients remain 
asymptomatic throughout life. 
• Some patients have severe 
symptoms of heart failure, 
arrhythmias, systemic 
embolism. 
• Some patients die suddenly, 
often in the absence of 
previous symptoms. 
en.wikipedia.org/wiki/Dilated_cardiomyopathy#Signs_and_symptoms pathologyoutlines.com/topic/heartdilated.html pathologyoutlines.com/topic/hearthypertrophic.html 
Diagnosis 
(Dilated Cardiomyopathy) 
  
https://en.wikipedia.org/wiki/Dilated_cardiomyopathy#Signs_and_symptoms clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/ 
• DCM is characterized by enlargement of the heart with a 
decreased shortening fraction (usually less than 25%), sinus 
tachycardia or atrial fibrillation,  left bundle-branch 
block (LBBB).   
• Genetic testing can help understand the underlying cause 
of the DCM. 
• DCM is usually identified when limiting symptoms are 
severe, but arrhythmias or sudden death are uncommonly 
early manifestations. 
• Arrhythmias in DCM are typically prominent only after the 
onset of significant heart failure. 
• A family history of DCM is present in over 50% of patients. 
Diagnosis 
(Dilated Cardiomyopathy with Mural Thrombus) 
  
https://i.ytimg.com/vi/FtcDPkKE6to/hqdefault.jpg 
Diagnosis 
(Dilated Cardiomyopathy following Trastuzumab 
Chemotherapy) 
http://medind.nic.in/ibi/t12/i1/ibit12i1p131.htm 
Diagnosis 
(Dilated Cardiomyopathy: The Veteran Athlete’s Heart) 
  
http://www.aspetar.com/journal/viewarticle.aspx?id=33#.V39bWLiLQhc 
Diagnosis 
(Dilated Cardiomyopathy: Chest Radiograph) 
  
http://emedicine.medscape.com/article/348284-overview 
Diagnosis 
(Hypertrophic Cardiomyopathy) 
  
http://emedicine.medscape.com/article/152913-overview#showall 
• No specific laboratory blood tests are required.  
• Genetic testing is not yet widely available. 
• Imaging data: abnormal systolic anterior leaflet motion of 
the mitral valve, LVH, left atrial enlargement, small 
ventricular chamber size, septal hypertrophy with septal-to-
free wall ratio greater than 1.4:1, mitral valve prolapse, 
mitral regurgitation, decreased midaortic flow, partial 
systolic closure of the aortic valve in midsystole. 
• Electrocardiography (ECG): ST-T wave abnormalities and 
LVH, axis deviation, conduction abnormalities, sinus 
bradycardia, ectopic rhythm, atrial enlargement, abnormal 
and prominent Q wave in the anterior precordial and lateral 
limb leads, atrial fibrillation,  etc. 
 
 
 
Diagnosis 
(Hypertrophic Cardiomyopathy) 
http://2.bp.blogspot.com/-FLBZEezZ9kg/VBSgVem1leI/AAAAAAAABx4/Ztwyi3saNtE/s1600/cardiaccompassmmodewithwithleftventricalcalc.jpeg 
Diagnosis 
(Hypertrophic Cardiomyopathy) 
http://www.med.umich.edu/lrc/coursepages/m1/anatomy2010/html/clinicalcases/cardiomegaly/cardiomegaly.html 
Diagnosis 
(Hypertrophic Cardiomyopathy: Midventricular 
Obstructive) 
http://journals.lww.com/jcardiovascularmedicine/Abstract/2015/11000/Clinical_characteristics_and_prognosis_of_60.4.aspx 
Abnormal ECG in a patient with hypertrophic cardiomyopathy. 
Note the T wave inversion and ST depression in the 
inferolateral leads (arrows) 
Diagnosis 
(Hypertrophic Cardiomyopathy in Athletes) 
  
http://emedicine.medscape.com/article/348284-overview 
Abnormal ECG in a patient with hypertrophic cardiomyopathy. 
Note the T wave inversion and ST depression in the 
inferolateral leads (arrows) 
 US MLE TEST 
A 58-year-old man presents to his primary care doctor complaining of 
several months of worsening shortness of breath and ankle swelling. He 
has no significant past medical or surgical history. His temperature is 37 
C (98.6 F), pulse is 78, blood pressure is 130/72 mm Hg, and respiratory 
rate is 16. He has elevated jugular venous pressure, diminished breath 
sounds at the lung bases, tender hepatomegaly, and bilateral pitting 
ankle edema. There are no murmurs, rubs, or gallops. His chest x-ray 
shows a normally sized heart and bilateral pleural effusions. 
Echocardiography shows symmetrical thickening of the left ventricle, 
normal left ventricular volume, and mildly reduced systolic function. 
Which of the following lab tests would help identify a reversible cause of 
this patient's illness?   
1.  Liver function tests, 2.  Transferrin saturation, 3.  Serum protein 
electrophoresis, 4.  Antitopoisomerase antibodies , 5.  Serum 
angiotensin converting enzyme (ACE) levels.  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient has congestive heart failure secondary to 
restrictive cardiomyopathy. Hereditary hemochromatosis is a reversible 
cause of restrictive cardiomyopathy and is diagnosed by measuring 
serum transferrin saturation. 
Incorrect Answers: 1: Although hemochromatosis does cause 
hepatocellular damage resulting in elevated LFTs, this test is nonspecific 
for diagnosing hemochromatosis, 3: Serum protein electrophoresis 
would aid in the diagnosis of systemic amyloidosis, which is generally 
considered irreversible, 4: Antitopoisomerase antibodies are measured 
to diagnose systemic sclerosis, which is also an irreversible condition, 5: 
ACE levels are sometimes used to help diagnose sarcoidosis, an 
irreversible cause of restrictive cardiomyopathy. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Treatment 
(Dilated Cardiomyopathy) 
• Essentially the same as treatment of chronic heart failure 
(HF). 
• Drug therapy can slow down progression and in some cases 
even improve the heart condition and may include salt 
restriction, angiotensin converting enzyme (ACE) 
inhibitors, diuretics, anticoagulants. 
• Surgery: artificial pacemakers;  implantable cardioverter-
defibrillators;  ventricular remodeling, heart 
transplantation may be considered.  
 
https://en.wikipedia.org/wiki/Dilated_cardiomyopathy#Signs_and_symptoms 
Treatment 
(Hypertrophic Cardiomyopathy) 
• A significant number of patients do not have any symptoms 
and will have normal life expectancies, though they should 
be counseled to avoid particularly strenuous activities or 
competitive athletics.  
• In patients with resting or inducible outflow obstructions, 
situations that will cause dehydration or vasodilation 
should be avoided.   
• The primary goal of medications is to relieve symptoms, 
and  first-line agents include beta blockers and calcium 
channel blockers (verapamil). 
• Surgery: septal myectomy, septal ablation, implantable 
pacemaker or defibrillator, cardiac transplantation. 
https://en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy#Treatment 
Prognosis  
• DCM:  survival rate of less than 50% at 10 years; there is a 
negative association  survival with frequent ventricular 
tachyarrhythmias that require antiarrhythmic treatment or 
automated implantable cardioverter-defibrillator (AICD) 
placement. 
• HCM: annual mortality rates of up to 6% , important 
independent predictors of mortality are mutations in the b-
MHC, occurrence of atrial fibrillation, stroke, presence of 
basal outflow obstruction of at least 30 mm Hg and marked 
left ventricular wall thickness of more than 25 mm.  
http://emedicine.medscape.com/article/2017823-overview#a4 http://pathologyoutlines.com/topic/hearthypertrophic.html 
Prophylaxis 
• Cardiomyopathy may be due to an underlying diseases or 
conditions.  
• Treating that conditions early enough may help prevent 
cardiomyopathy complications.  
• Sudden cardiac arrest (SCA) may be prevented in patients 
at high risk if they are treated with an implantable 
cardioverter defibrillator. 
en.wikipedia.org/wiki/Supraventricular_tachycardia#Medications 
Abbreviations  
ACE – angiotensin converting enzyme  
Ao -ascending aorta 
ARVC - arrhythmogenic right ventricular cardiomyopathy  
DCM - dilated cardiomyopathy  
ECG – electrocardiography 
HCM - hypertrophic cardiomyopathy 
HF - chronic heart failure 
LA - left atrium 
LBBB - left bundle-branch block  
LV - left ventricle 
MV - mitral valve  
SCA - sudden cardiac arrest 
 
Diagnostic and treatment guidelines 
2014 ESC Guidelines on diagnosis and management of 
hypertrophic cardiomyopathy 
Hypertrophic Cardiomyopathy 
Dilated Cardiomyopathy  
